Submission Details
| 510(k) Number | K250159 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 21, 2025 |
| Decision Date | October 17, 2025 |
| Days to Decision | 269 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K250159 is an FDA 510(k) clearance for the Immunoglobulin Isotypes (GAM) for the EXENT Analyser; EXENT Analyser, a Mass Spectrometric, Immunoglobulins (g, A, M, D, E) (Class II — Special Controls, product code SGG), submitted by The Binding Site Group , Ltd. (Birmingham, GB). The FDA issued a Cleared decision on October 17, 2025, 269 days after receiving the submission on January 21, 2025. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5510.
| 510(k) Number | K250159 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 21, 2025 |
| Decision Date | October 17, 2025 |
| Days to Decision | 269 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | SGG — Mass Spectrometric, Immunoglobulins (g, A, M, D, E) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5510 |
| Definition | The Test System Is Intended For The (semi-)quantitative Or Quantitative Determination Of Monoclonal Immunoglobulins (m-proteins) And/or The Identification Of Immunoglobulin Isotype Of M-proteins In Human Specimens By Mass Spectrometric Methods. |